Paul M Mystkowski, MD in Bellevue, WA - Internal Medicine

Paul M Mystkowski, MD is a Internal Medicine - Endocrinology, Diabetes & Metabolism physician based in Bellevue, Washington. Paul M Mystkowski is licensed to practice in Washington (license number MD00035801) and his current practice location is 1407 116th Ave Ne, Suite 200, Bellevue, Washington. He can be reached at his office (for appointments etc.) via phone at (425) 454-5046.

NPI number for Paul M Mystkowski is 1073609699 and his current mailing address is 1407 116th Ave Ne, Suite 200, Bellevue, Washington. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1073609699.

Contact Information

	Paul M Mystkowski, MD
	1407 116th Ave Ne, Suite 200, Bellevue, WA 98004-3819
	(425) 454-5046
	Not Available

Physician's Profile

Full Name	Paul M Mystkowski
Gender	Male
Speciality	Internal Medicine - Endocrinology, Diabetes & Metabolism
Location	1407 116th Ave Ne, Bellevue, Washington
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1073609699
Provider Enumeration Date: 10/04/2006
Last Update Date: 05/13/2008

Medical Identifiers

Medical identifiers for Paul M Mystkowski such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1073609699	NPI	-	NPPES
8239667	Medicaid	WA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RE0101X	Internal Medicine - Endocrinology, Diabetes & Metabolism	MD00035801 (Washington)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Paul M Mystkowski is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Paul M Mystkowski, MD 1407 116th Ave Ne, Suite 200, Bellevue, WA 98004-3819 Ph: (425) 454-5046	Paul M Mystkowski, MD 1407 116th Ave Ne, Suite 200, Bellevue, WA 98004-3819 Ph: (425) 454-5046

News Archive

FDA approves Genentech's Erivedge for treatment of BCC

Genentech, a member of the Roche Group, today announced that Erivedge (vismodegib) capsule was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with a type of skin cancer, called basal cell carcinoma (BCC), that has spread to other parts of the body or that has come back after surgery or that their healthcare provider decides cannot be treated with surgery or radiation.

Framework agreement creates safe blood for China

In an important step to help combat the spread of HIV/AIDS in China, The People's Republic of China's Ministry of Health signed a groundbreaking framework agreement with Washington, D.C.-based Safe Blood International Foundation (Safe Blood International), an organization dedicated to providing a safe blood supply for developing countries to help them stop the spread of HIV/AIDS and other blood-borne diseases at the Ministry of Health in Beijing.

Hospitals directed to step up protections for kidney donors

Addressing long-held concerns about whether organ donors have adequate protections, the country's transplant regulators acted late Monday to require that hospitals thoroughly inform living kidney donors of the risks they face, fully evaluate their medical and psychological suitability, and then track their health for two years after donation.

UBC research reveals pregnancy rates of transgender youth similar to other young people

Sexually active transgender youth have pregnancy rates similar to their non-transgender peers-dispelling the notion that trans youth are less at risk for pregnancy, according to new UBC research.

Research shows IFITM3 protein can block Zika virus from infecting human, mouse cells

Eight weeks after receiving their first samples of Zika virus, scientists at the University of Massachusetts Medical School have shown that a very small protein we all have in our bodies, interferon-induced protein 3 (IFITM3), can dramatically reduce the ability of Zika virus to infect human and mouse cells.

Internal Medicine Doctors in Bellevue, WA

Joseph W Doucette, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1135 116th Ave Ne, Suite 600, Bellevue, WA 98004 Phone: 425-454-2656 Fax: 425-990-5261
Roanne R E Selinger, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1135 116th Ave Ne, #560, Bellevue, WA 98004 Phone: 425-454-4768 Fax: 425-462-8021
Patsy C Lazarous, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 Fax: 844-620-1839
Dr. Patricia Martin, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1407 116th Ave Ne, Suite 200, Bellevue, WA 98004 Phone: 425-454-5046 Fax: 425-990-5261
Dr. Rahil Barketali Roopani, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1800 116th Ave Ne Ste 102, Bellevue, WA 98004 Phone: 425-947-9485 Fax: 425-977-9034
David C Morton, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1135 116th Ave Ne, Suite 110a, Bellevue, WA 98004 Phone: 425-289-3100 Fax: 425-289-3103
Shie-pon Tzung, MD PHD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1135 116th Ave Ne, #560, Bellevue, WA 98004 Phone: 425-454-4768 Fax: 425-462-8021

Paul M Mystkowski, MD - Internal Medicine in Bellevue, WA